Chung‐Hsiang Yang

797 citations
23 papers · 645 indexed · h-index 11
Topics
SARS-CoV-2 and COVID-19 Research (4 papers)Folate and B Vitamins Research (3 papers)Biochemical and Molecular Research (3 papers)
Partner nations
TaiwanUnited StatesJapan

In The Last Decade

Chung‐Hsiang Yang

23 papers receiving 637 citations

Peers

Chung‐Hsiang Yang
Comparison fields: 5 of 96
  • Molecular Biology 421
  • Oncology 153
  • Cell Biology 71
  • Infectious Diseases 62
  • Cancer Research 61
Replace Lili Gong with:
Lili Gong China
Myrtani Pieri Cyprus
Jin Yao United States
Huizhi Wang China
Kelly A. Kaihara United States
Shabana Shabbeer United States
Zhou Jiang China
Yap Ching Chew United States
Sen Wang China
Chung‐Hsiang Yang relative to Lili Gong China Lili Gong's profile →
Citations per field
00.5×3.3×
Lili Gong · 1×
Citations per year

Countries citing papers authored by Chung‐Hsiang Yang

Since Specialization
Citations

This map shows the geographic impact of Chung‐Hsiang Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chung‐Hsiang Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chung‐Hsiang Yang more than expected).

Fields of papers citing papers by Chung‐Hsiang Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chung‐Hsiang Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chung‐Hsiang Yang. The network helps show where Chung‐Hsiang Yang may publish in the future.

Co-authorship network of co-authors of Chung‐Hsiang Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Chung‐Hsiang Yang. A scholar is included among the top collaborators of Chung‐Hsiang Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chung‐Hsiang Yang. Chung‐Hsiang Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 5
2 15
3 10
4 4
5 33
6 27
7 1
8 1
9 7
10 6
11 15
12 8
13 6
14 5
15 5
16 15
17 29
18 309
19 8
20 12

About Chung‐Hsiang Yang

Chung‐Hsiang Yang is a scholar working on Sensory Systems, Infectious Diseases and Biochemistry, having authored 23 papers that have together received 645 indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (4 papers), Folate and B Vitamins Research (3 papers) and Biochemical and Molecular Research (3 papers). The work is most often cited by research in Molecular Biology (421 citations), Oncology (153 citations) and Aging (8 citations). Chung‐Hsiang Yang has collaborated with scholars based in Taiwan, United States and Japan. Frequent co-authors include Chi-Wu Chiang, Yu-San Yang, Yi-Chun Kuo, Francis M. Sirotnak, June L. Biedler, Chia‐Hsiung Cheng, Wan‐Chung Hu, Yi‐Chung Chen, Kuo‐Wang Tsai and Chia‐Chao Wu. Their work appears in journals such as Journal of Biological Chemistry, PLoS ONE and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026